Cargando…
Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis
Idiopathic pulmonary fibrosis is a lethal disease driven by myofibroblast expansion. Currently no therapies exist that target the epigenetic mechanisms controlling myofibroblast transdifferentiation, which is responsible for unregulated extracellular matrix (ECM) production. We have recently shown t...
Autores principales: | Bernau, Ksenija, Skibba, Melissa, Leet, Jonathan P., Furey, Sierra, Gehl, Carson, Li, Yi, Zhou, Jia, Sandbo, Nathan, Brasier, Allan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245900/ https://www.ncbi.nlm.nih.gov/pubmed/35782526 http://dx.doi.org/10.3389/fmmed.2022.842558 |
Ejemplares similares
-
Role of Secretoglobin(+) (club cell) NFκB/RelA-TGFβ signaling in aero-allergen-induced epithelial plasticity and subepithelial myofibroblast transdifferentiation
por: Skibba, Melissa E., et al.
Publicado: (2021) -
Pdgfra marks a cellular lineage with distinct contributions to myofibroblasts in lung maturation and injury response
por: Li, Rongbo, et al.
Publicado: (2018) -
Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis
por: Bernau, Ksenija, et al.
Publicado: (2015) -
Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis
por: Skibba, Melissa, et al.
Publicado: (2020) -
Orchestrating epigenetic readers: Progress in understanding the functions of bromodomain-containing protein 4 complexes
por: Brasier, Allan R.
Publicado: (2023)